Skip to main content
. 2017 Apr 20;27(2):169–178. doi: 10.18865/ed.27.2.169

Table 1. Germline mutations identified in 31 African American high-risk breast cancer patients.

Gene ID SNP Rs# Nucleotide or N % Mean age ± SD, years Molecular consequences ClinVar Worst clinical significance (SIFT, PolyPhen)
Amino acid change
BRCA1 55975699 Asp232Asn 1 3.23 36 ± na missense VUS Possibly pathogenic
397507258 Asn319Ser 1 3.23 44 ± na missense VUS VUS
373202012 c.441+52delC 2 6.45 30.5 ± 2.1 intron Not found in ClinVar VUS
578250989 c.441+51T>C 16 51.61 37.1 ± 6.3 intron Not found in ClinVar VUS
novel c.441+54A>G 1 3.23 37 ± na intron VUS VUS
BRCA2 80359304 Met591Ile 1 3.23 41 ± na frameshift Pathogenic Pathogenic
56328701 Asp596His 1 3.23 37 ± na missense VUS Possibly pathogenic
45469092 Arg2973Cys 1 3.23 32 ± na missense VUS Possibly pathogenic
206076 Val2171Val 31 100.0 37.9 ± 5.8 synonymous VUS VUS
56014558 c.7007+53G>A 1 3.23 43 ± na intron Not found in ClinVar VUS
76584943 c.7008-62A>G 1 3.23 32 ± na intron VUS VUS

VUS, variant of unknown significance.